Form Bio for  Biomanufacturing

The new age of pharmacology is upon us. From gene therapy to viral vectors, our expert teams have built a platform that grows with you.  From the first steps of drug discovery and pre-clinical studies through scaling for manufacturing, we advance your efforts and empower your teams to derive ready to use outputs that match the rigor of regulatory requirements.

We know you face a litany of challenges in analyzing the volumes of data involved in the clinical trials and manufacturing process.  Interpreting the data is time consuming and challenging within the constraints of using a bioinformatics core, and ensuring that these processes and outputs comply with regulatory requirements creates even more lag in your timelines.  The experts at Form have broken down the complexities faced to create simple, intuitive solutions that empower you to do more, and do it more efficiently.

Workflows tab - Activity - Public screen illustration

Benefits for Biomanufacturing Team

Choosing Form to be your computational sciences solution provider reduces the time spent waiting for steps to be completed while simultaneously allowing for improved collaboration and insights generation.  Here are just a few of the benefits you can count on:

What Biomanufacturing Teams Can Do With Form

Here are just a few ways we help:

Upload and organize your data with ease and compliance

Pick from our growing list of verified workflows and run them with a click

Visualize your workflow results in presentation-quality charts and graphs

Easily invite and collaborate with colleagues and stakeholders

Example Use Cases

Form opens up virtually unlimited opportunities for you to take on consequential research that might be extraordinarily challenging otherwise. But here are just a few examples:

Analyze the data generated from High-Throughput Screens (HTS) to better identify drug leads

Development of data outputs illustrating drug targets that affect targeted molecules in the validation process

Improved Phase I-III analysis of clinical trials data via the application of data visualization and collaboration capabilities

Execute CRISPR base editing and knockout functions

Solution Spotlight


The Cell and Gene Therapy Design Upgrade for the AI Era

Example improvements on a publicly traded gene therapy company’s AAV construct.


Why It Matters

Reduce Manufacturing Costs

by avoiding costly bioreactor runs on suboptimal construct designs

Shorten Time-to-Market

by minimizing design inefficiencies that prolong manufacturing trial-and-error

Enhance Safety

by predicting and optimizing capsid fill proportion with therapeutic drug product to streamline production scaling

Extend IP Protection

by filing fresh patents on optimized construct derivatives generated with FORMsightAI

blobs image
Solution Spotlight

Candidate Validation

Improve gene therapy manufacturability.

Sitting atop the Form platform, our Candidate Validation solution optimizes constructs—helping potentially breakthrough therapies get to the production stage with less trial and error.

Why It Matters

Reduce Time to Market

Get novel therapies to market faster by avoiding the holdups that come with CpG islands,  secondary structure truncation and suboptimal codon usage.

Increase Manufacturing Efficiencies

Optimize constructs for manufacturing viability, reducing the likelihood of therapy candidates that fail in production.

Reduce R&D Overspend

Save days, weeks or months of capital burn by accelerating the manufacturing path to revenue.

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

Alex Smit
Founder of Stic

As a Form Bio customer, we are thrilled with the uniquely valuable AI-driven insights they’ve contributed to our research and development efforts. By working closely with this world class team and cutting edge technology, we can clearly see that applying innovative AI solutions to pre-clinical cell and gene therapy development offers exciting potential for CGT companies’ economics, market timing and ability to impact human health.

Jenny Marlowe, PhD
Chief Scientific Officer, Solid Biosciences

Computer-aided design, fabrication, testing analyses and machine learning are key to the future of bioengineering in general and specifically restoration of endangered and extinct genetic diversity for keystone species in vital ecosystems. Form Bio is the software critical to pave the way.

George Church, PhD
Professor, Harvard Medical School and MIT; Director of Synthetic Biology, The Wyss Institute

Form Bio helps Colossal's biology teams save time and maximize our research in ways we didn’t realize were possible. Having access to an incredibly easy-to-use interface coupled with Form’s deep bench of bioinformatics and data science expertise is core to our workflows and how we fulfill our ambitious research objectives.

Eriona Hysolli, PhD
Head of Biological Sciences, Colossal Biosciences

"Form Bio’s platform and experienced team are playing an indispensable role in our conservation and de-extinction research initiatives. The software’s ease-of-use and breadth of capabilities empower scientists to get more computational work done with less effort and in less time, making it a critical part of how we reach our discoveries."

Andrew Pask, PhD
Professor of Biosciences, University of Melbourne

Our collaboration with Form Bio is enabling our group to build more replicable workflows that allow us to perform routine analysis with greatly reduced analyst time—addressing a critical bottleneck in the scientific enterprise.

Vagheesh Narasimhan, PhD
Assistant Professor Department of Integrative Biology, Department of Statistics and Data Sciences, The University of Texas at Austin